Exercise & Nutrition Research Program, The Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, VIC 3065, Australia.
Research Institute for Sport and Exercise, University of Canberra, Bruce, ACT 2617, Australia.
Nutrients. 2022 May 5;14(9):1929. doi: 10.3390/nu14091929.
We implemented a multi-pronged strategy (MAX) involving chronic (2 weeks high carbohydrate [CHO] diet + gut-training) and acute (CHO loading + 90 g·h−1 CHO during exercise) strategies to promote endogenous and exogenous CHO availability, compared with strategies reflecting lower ranges of current guidelines (CON) in two groups of athletes. Nineteen elite male race walkers (MAX: 9; CON:10) undertook a 26 km race-walking session before and after the respective interventions to investigate gastrointestinal function (absorption capacity), integrity (epithelial injury), and symptoms (GIS). We observed considerable individual variability in responses, resulting in a statistically significant (p < 0.001) yet likely clinically insignificant increase (Δ 736 pg·mL−1) in I-FABP after exercise across all trials, with no significant differences in breath H2 across exercise (p = 0.970). MAX was associated with increased GIS in the second half of the exercise, especially in upper GIS (p < 0.01). Eighteen highly trained male and female distance runners (MAX: 10; CON: 8) then completed a 35 km run (28 km steady-state + 7 km time-trial) supported by either a slightly modified MAX or CON strategy. Inter-individual variability was observed, without major differences in epithelial cell intestinal fatty acid binding protein (I-FABP) or GIS, due to exercise, trial, or group, despite the 3-fold increase in exercise CHO intake in MAX post-intervention. The tight-junction (claudin-3) response decreased in both groups from pre- to post-intervention. Groups achieved a similar performance improvement from pre- to post-intervention (CON = 39 s [95 CI 15−63 s]; MAX = 36 s [13−59 s]; p = 0.002). Although this suggests that further increases in CHO availability above current guidelines do not confer additional advantages, limitations in our study execution (e.g., confounding loss of BM in several individuals despite a live-in training camp environment and significant increases in aerobic capacity due to intensified training) may have masked small differences. Therefore, athletes should meet the minimum CHO guidelines for training and competition goals, noting that, with practice, increased CHO intake can be tolerated, and may contribute to performance outcomes.
我们实施了一种多管齐下的策略(MAX),包括慢性(2 周高碳水化合物[CHO]饮食+肠道训练)和急性(CHO 负荷+运动时 90 g·h−1 CHO)策略,以促进内源性和外源性 CHO 的可用性,与两组运动员中反映当前指南较低范围的策略(CON)相比。19 名精英男性竞走运动员(MAX:9;CON:10)在各自干预前后进行了 26 公里竞走比赛,以调查胃肠道功能(吸收能力)、完整性(上皮损伤)和症状(GIS)。我们观察到个体反应存在相当大的差异,导致运动后所有试验中 I-FABP 统计学上显著(p < 0.001)但可能临床上无意义的增加(Δ 736 pg·mL−1),而运动过程中呼气 H2 无显著差异(p = 0.970)。MAX 与运动后半段 GIS 增加有关,尤其是上 GIS(p < 0.01)。然后,18 名高训练有素的男性和女性长跑运动员(MAX:10;CON:8)分别采用稍作修改的 MAX 或 CON 策略,完成 35 公里跑步(28 公里稳态+7 公里计时赛)。尽管干预后 MAX 组运动中 CHO 摄入量增加了 3 倍,但由于个体差异,上皮细胞肠脂肪酸结合蛋白(I-FABP)或 GIS 并没有因运动、试验或组而出现明显差异。从干预前到干预后,两组的紧密连接(闭合蛋白-3)反应均降低。从干预前到干预后,两组的表现均有所提高(CON = 39 s [95%CI 15−63 s];MAX = 36 s [13−59 s];p = 0.002)。尽管这表明,在当前指南之上进一步增加 CHO 的可用性不会带来额外的优势,但我们研究执行的局限性(例如,尽管在一个生活营环境中,但仍有几个人的 BM 大量流失,由于强化训练,有氧能力显著增加)可能掩盖了微小的差异。因此,运动员应满足训练和比赛目标的最低 CHO 指南,同时注意到,随着实践的增加,CHO 的摄入量是可以耐受的,并可能有助于提高表现。